Drug intelligence / Profile preview

ido-BR1

Development stage
Preclinical
Lead developer
IminoTech
Modality
Small Molecules
Administration
Oral
01

Overview

ido-BR1 is a naturally occurring iminosugar small molecule developed by Phytoquest, primarily isolated from *Cucumis sativus* (cucumber). It functions as a glycosidase inhibitor with significant anti-inflammatory activity. Marketed under the brand name Q-Actin as a dietary supplement, it has been clinically shown to improve joint function and reduce pain in patients with osteoarthritis. Beyond joint health, Phytoquest is investigating ido-BR1 for its neuroprotective properties and potential in maintaining brain health, as iminosugars can cross the blood-brain barrier and modulate various cellular pathways involved in neuroinflammation and protein folding.

Brand names
Q-Actin
Other names
1,4-dideoxy-1,4-imino-D-ribitolcucumber iminosugar
02

Targets

BGL (beta-Glucosidase)CD44 (CD44 antigen)AG (Alpha-glucosidase (Bacillus))

Beyond the preview

Go deeper on ido-BR1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ido-BR1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call